ASYMMETRICALLY POROUS ION EXCHANGE MEMBRANES AND THEIR METHOD OF MANUFACTURE
20180333682 ยท 2018-11-22
Inventors
Cpc classification
B01D2325/14
PERFORMING OPERATIONS; TRANSPORTING
B01D2325/16
PERFORMING OPERATIONS; TRANSPORTING
B01D2325/023
PERFORMING OPERATIONS; TRANSPORTING
B01D2325/0231
PERFORMING OPERATIONS; TRANSPORTING
B01D67/00933
PERFORMING OPERATIONS; TRANSPORTING
B01D69/02
PERFORMING OPERATIONS; TRANSPORTING
B01D71/5223
PERFORMING OPERATIONS; TRANSPORTING
International classification
B01D67/00
PERFORMING OPERATIONS; TRANSPORTING
B01D69/02
PERFORMING OPERATIONS; TRANSPORTING
B01D61/24
PERFORMING OPERATIONS; TRANSPORTING
Abstract
The invention relates to a membrane and method for its manufacture, the method including the steps of (1) providing of an ultrafiltration membrane, and (2) modification of the resultant ultrafiltration membrane to provide an asymmetric porous ion exchange membrane. The modification of the ultrafiltration membrane is typically carried out by (i) exposing said ultrafiltration membrane to a first functional reagent to provide a cross-linked ultrafiltration membrane, and then (ii) exposing said cross-lined ultrafiltration membrane to a second functional reagent to introduce positive charged groups to produce an anion exchange membrane.
Claims
1. A method for manufacture of a membrane comprising the steps of (1) provision of an ultrafiltration membrane, and (2) modification of the resultant ultrafiltration membrane to provide an asymmetric porous ion exchange membrane.
2. A method according to claim 1 wherein the ultrafiltration membrane comprises at least one halogen methylated polymer.
3. A method according to claim 1 wherein the asymmetric porous ion exchange membrane comprises, a dense top surface without observable pores, a thin nanoporous active layer, a macroporous supporting layer with asymmetrically porous channels within the cross section, and a macroporous bottom surface
4. A method according to claim 1 wherein step (1) comprises the steps of; (1)(i) forming a solution comprising 10-40 wt % of one or more halogen methylated polymers, (1)(ii) casting the solution to a thickness of 10-500 micron, and (1)(iii) subjecting the cast solution to a coagulation bath to form an ultrafiltration membrane.
5. A method according to claim 1 wherein step (2) comprises the sub-step of exposing the ultrafiltration membrane of step (1) to a bis-functional reagent including an imidazoles or amine containing at least two amine groups.
6. A method according to claim 1 wherein step (2) comprises the sub-steps of, (i) exposing said ultrafiltration membrane to a first functional reagent to provide a cross-linked ultrafiltration membrane, and then (ii) exposing said cross-linked ultrafiltration membrane to a second functional reagent to introduce positive charged groups to produce an anion exchange membrane.
7. A method according to claim 6 wherein the second functional reagent is selected from molecules that can be transferred to positively charged compound after reaction with halomethyl, including N-substituted imidazole, tris(3,5-dimethylphenyl)phosphine, tris(2,4,6-trimethoxyphenyl)phosphine, tris(2,4,6-trimethylphenyl)phosphine, tris(3,5-dimethylphenyl)phosphine, or amines molecules with a tertiary amine group such as trimethylamine, tripropylamine and trihexylamine or mixtures thereof.
8. A method according to claim 1 wherein step (2) comprises the sub-steps of; (i) exposing said ultrafiltration membrane to a first functional reagent to provide a cross-linked ultrafiltration membrane, and then (ii) exposing said cross-linked ultrafiltration membrane to a second functional reagent to introduce negatively charged groups to produce a cation exchange membrane.
9. A method according to claim 8 wherein the second functional reagent is selected from molecules that can and introduce negatively charged groups after reaction with membrane including concentrated sulfuric acid, chlorosulfonic acid, potassium 4-(1H-indol-3-yl)butanoate, 3-Indoleacetic acid, or Indole-3-butyric acid.
10. An ultrafiltration membrane manufactured according to the method of claim 1, wherein the membrane comprises, a dense top surface without observable pores, a thin nanoporous active layer, a macroporous supporting layer with asymmetrically porous channels within the cross section, and a macroporous bottom surface.
11. A diffusion dialysis membrane manufactured according to the method of claim 1.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0050] Further disclosure, objects, advantages and aspects of preferred and other embodiments of the present application may be better understood by those skilled in the relevant art by reference to the following description of embodiments taken in conjunction with the accompanying drawings, which are given by way of illustration only, and thus are not limitative of the disclosure herein, and in which:
[0051]
[0052]
[0053]
TABLE-US-00001 1 - addition of organic solvent to a polymer to form a polymer solution 3 - applying a micrometer film applicator 5 - applying to a substrate 7 - forming a casting solution 9 - subjecting the casting solution of af a coagulation bath 11 - formation of an ultrafiltration membrane 13 - formation of halogen methylated polymers 15 - modification of the ultrafiltration membrane by addition of a bis-functional reagent 17 - formation of a porous anion exchange membrane 19 - addition of a first functional reagent to cause cross-linking 21 - addition of an alternative second functional reagent to introduce positively charged groups 23 - formation of a cross-linked ultrafiltration membrane 25 - formation of a porous anion exchange membrane 27 - addition of another second functional reagent to introduce negatively charged groups 29 - formation of a porous cation exchange membrane
[0054]
[0055]
[0056]
[0057]
[0058]
DETAILED DESCRIPTION
[0059] In contradistinction to dense membranes, ultrafiltration membranes have a thin nanoporous skin layer with a thickness of sub-micrometer and a thick and macroporous supporting layer. Typical ultrathin membranes of the prior art are described by Guillen et al., in Preparation and Characterization of Membranes Formed by Nonsolvent Induced Phase Separation: A Review, Industrial & Engineering Chemistry Research, 2011, 50(7), p. 3798-3817. High acid/base permeability can be expected after the nanopores of the skin layer have been blocked.
[0060] Typically, the transport of small molecules across a dense or nonporous polymer membrane follows a solution-diffusion mechanism involving sorption of solutes into the membrane, diffusion across the membrane and desorption of solutes out of the membrane. Among these process, diffusion across the membrane under a hopping mechanism or vehicular mechanism is the most important and largely dependent on the free volume of the polymer.
[0061]
[0062] For dense anion exchange membrane, ion transfer rate is low because of the less free volume and the high thickness (dozens to hundreds ?m). For asymmetrically porous anion exchange membranes, protons may firstly transport through the thin skin layer (typically <1 ?m thick) via nano-channels. The transport rate should be higher than dense membrane with the same thickness because of the larger free volume. Afterwards, ion transport rate in the supporting layer should be accelerated because of the abundant water absorbed in the finger-linked macro-channels.
[0063] The proton diffusivity across the whole asymmetrically porous anion exchange membrane is significantly higher than the ion diffusivity across the dense anion exchange membrane. The difference in the micro-structure between the dense and ultrafiltration membrane results in the difference in ion transfer rate in the membrane matrix. Moreover, since ultrafiltration membranes can be conveniently prepared via a phase inversion technique (such as the technique disclosed in Lin et al, J. Membrane Sci., 2015, 482(0): p. 67-75) the conversion of ultrafiltration membranes is a simple and effective method for the large-scale production of diffusion dialysis membranes with high-performance.
[0064]
[0065] Same to the mechanism described for the asymmetrically porous anion exchange membrane, the hydroxide diffusivity across the whole asymmetrically porous cation exchange membrane is significantly higher than the hydroxide diffusivity across the dense cation exchange membrane. Therefore high base permeability can be obtained.
Manufacture of the Ultrafiltration Membrane
[0066] Step (1) of the method of manufacture according to the present invention comprises preparation of an ultrafiltration membrane using a polymer. As mentioned previously the polymer can be selected from many halogen methylated polymers such as chloromethylated polysulfone (PS-Cl), chloromethylated polyethersulfone (PES-Cl), chloromethylated poly(ether ketone) (PEK-Cl), chloromethylated poly (ether ether ketone) (PEEK-Cl), chloromethylated poly (phthalazinone ether sulfone ketone) (PPESK-Cl) and bromomethylated poly (phenylene oxide) (BPPO).
[0067] The polymer is typically dissolved. The organic solvent used for dissolving the polymer can be a single solvent or a mixture of solvents. In a preferred embodiment the solvent is chosen from the group comprising N-methyl-2-pyrrolidone (NMP), dimethylformamide (DMF), dimethylacetamide (DMAC), or mixtures thereof. The choice of solvent(s) will depend on the types of polymers used in the membrane fabrication, and desired microstructure of the final membranes.
[0068] The halogen methylated polymer is dissolved in organic solvent to form a casting solution. Typically the polymer concentration is 10-40 wt %.
[0069] The solution is then cast with a typical thickness of 100-500 ?m. The casting may for example be carried out using a micrometer film applicator on a clean flat substrate (such as a glass plate). The ultrafiltration membrane may be produced in a coagulation bath filled with water or other solvents, followed by washing thoroughly in deionized water. The resulting membrane is soaked in deionized water for future modification.
[0070] The method of manufacturing a membrane according to the present invention is described in the following non-limiting Examples.
Example 1Manufacture Using a Single Modification Step for Anion Exchange Membrane Preparation
[0071] Commercial bromomethylated poly (phenylene oxide) (BPPO) was used for preparation of an ultrafiltration membrane according to the present invention. The BPPO was dissolved in N-methyl-2-pyrrolidone to form a casting solution, which was cast onto a glass by a micrometer film applicator and then immersed into distilled water as coagulation bath to get the ultrafiltration membrane with benzyl bromide groups (CH.sub.2Br) groups. The ultrafiltration membrane was then modified via one-step method by soaking in N,N,N,N-tetramethylethylenediamine (TEMED) aqueous solution to get the final porous TPPO anion exchange membrane.
[0072] The concentration and thickness of the casting solution, the concentration of TEMED as the bis-functional reagent and the soaking temperature and time of ultrafiltration membrane in the TEMED solution can be varied to fabricate the asymmetrically porous anion exchange membranes with different diffusion dialysis properties.
[0073] For example, when the concentration and thickness of the casting solution is 30 wt % and 250 ?m, respectively, the concentration of the bis-functional regent is 1 mol.Math.L.sup.?1, the soaking temperature and time are 30? C. and 4 hours, respectively, the resulting TPPO membrane has an acid dialysis coefficient of 0.043 m.Math.h-.sup.1 and separation factor of 73.8 when applied to recovery HCl from the mixture of HCl and FeCl.sub.2 aqueous solution as the model acidic waste solution, which are 4.1 times and 3.0 times greater than the commercial DF-120 membrane under identical testing condition.
[0074]
[0075] As shown in
Example 2Manufacture Using a Two Step Modification for Anion Exchange Membrane Preparation
[0076] Commercial bromomethylated poly (phenylene oxide) (BPPO) was used as the starting for ultrafiltration membrane preparation. It was dissolved in N-methyl-2-pyrrolidone to form a casting solution with the concentration of 30 wt %, which was cast onto a glass by a micrometer film applicator whose gap was set as 250 ?m and then immersed into distilled water to get the ultrafiltration membrane with benzyl bromide groups (CH.sub.2Br) groups. The ultrafiltration membrane was then modified via two-steps method by soaking in butanediamine (BTDA) aqueous solution to get the cross-linked BBPPO membrane and then soaking in trimethylamine (TMA) aqueous solution in turn to get the final porous BTPPO anion exchange membrane.
[0077] The concentration of BTDA and TMA aqueous solution as the first and second functional reagent, respectively, and the soaking temperature and time of ultrafiltration membrane in the BTDA and TMA solution respectively can be varied to fabricate the final porous membranes with different diffusion dialysis properties. For example, when the concentration of the BTDA solution was 1 mol.Math.L.sup.?1, the soaking temperature and time were 40? C. and 1 hour, the concentration of the TMA solution was 1 mol.Math.L.sup.?1, the soaking temperature and time were 60? C. and 6 hours. The resultant BTPPO ultrafiltration membrane had an acid dialysis coefficient of 0.062 m h.sup.?1 and separation factor of 30.4 when applied to recovery HCl from the mixture of HCl and FeCl.sub.2 aqueous solution, which are 6.3 times and 0.6 times greater than the commercial DF-120 membrane of the prior art under identical testing condition.
[0078] Similar to Example 1 described above, the newly formed peak at 402.4 ev for BTPPO membrane (as shown in
[0079] As shown in
[0080] The acid dialysis coefficient and separation factor of TPPO and BTPPO are plotted in
[0081] As clearly shown in
Example 3Manufacture Using a Two Step Modification for Cation Exchange Membrane Preparation
[0082] Commercial bromomethylated poly (phenylene oxide) (BPPO) was used as the starting material for ultrafiltration membrane preparation. It was dissolved in N-methyl-2-pyrrolidone to form a casting solution with the concentration of 30 wt %, which was cast onto a glass by a micrometer film applicator whose gap was set as 250 ?m and then immersed into distilled water to get the ultrafiltration membrane with benzyl bromide groups (CH2Br) groups. The ultrafiltration membrane was then modified via two-steps method by soaking in butanediamine (BTDA) aqueous solution to get the cross-linked BBPPO membrane and then soaking in chlorosulfonic acid aqueous solution in turn to get the final porous cation exchange membrane.
[0083] The concentration of BTDA and chlorosulfonic acid aqueous solution as the first and second functional reagent, respectively, and the soaking temperature and time of ultrafiltration membrane in the BTDA and chlorosulfonic acid solution respectively can be varied to fabricate the final porous membranes with different diffusion dialysis properties. The resultant asymmetrically porous cation membranes show good diffusion dialysis for base recovery and mechanical properties.
[0084] While this invention has been described in connection with specific embodiments thereof, it will be understood that it is capable of further modification(s). This application is intended to cover any variations uses or adaptations of the invention following in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains and as may be applied to the essential features hereinbefore set forth.
[0085] As the present invention may be embodied in several forms without departing from the spirit of the essential characteristics of the invention, it should be understood that the above described embodiments are not to limit the present invention unless otherwise specified, but rather should be construed broadly within the spirit and scope of the invention as defined in the appended claims. The described embodiments are to be considered in all respects as illustrative only and not restrictive.
[0086] Various modifications and equivalent arrangements are intended to be included within the spirit and scope of the invention and appended claims. Therefore, the specific embodiments are to be understood to be illustrative of the many ways in which the principles of the present invention may be practiced. In the following claims, means-plus-function clauses are intended to cover structures as performing the defined function and not only structural equivalents, but also equivalent structures.
[0087] Comprises/comprising and includes/including when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof. Thus, unless the context clearly requires otherwise, throughout the description and the claims, the words comprise, comprising, includes, including and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of including, but not limited to.